ISRG · CIK 0001035267 · operating
Intuitive Surgical develops, manufactures, and markets robotic-assisted surgical systems and related instruments for minimally invasive procedures. The company's flagship product is the da Vinci Surgical System, which allows surgeons to perform operations through small incisions using robotic manipulation technology. The company also offers the Ion endoluminal system, which extends its product portfolio into diagnostic procedures, enabling minimally invasive lung biopsies. Beyond equipment, Intuitive Surgical provides consumable instruments including staplers and energy devices designed for use with its multi-port surgical platforms.
Revenue is generated through the sale of surgical systems to hospitals and surgical centers, as well as recurring revenue from consumable instruments, service contracts, and maintenance agreements. The company operates a direct sales model with dedicated capital equipment and clinical sales teams. Service offerings include system installation, repair, maintenance, 24/7 technical support, and proactive monitoring capabilities. Intuitive Surgical has also integrated digital tools into its platform to provide hospitals with performance analytics and operational insights.
The company operates globally with headquarters in Sunnyvale, California, and approximately 17,021 full-time employees. Intuitive Surgical sells to healthcare providers in the United States and internationally. The company was incorporated in Delaware in 1995 and is listed on the Nasdaq stock exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $7.87 | $8.00 | +22.6% | |
| 2024 | $6.42 | $6.54 | +27.6% | |
| 2023 | $5.03 | $5.12 | +37.8% | |
| 2022 | $3.65 | $3.72 | +254.4% | |
| 2021 | $1.03 | $1.07 | -65.9% | |
| 2020 | $3.02 | $3.11 | +1.0% | |
| 2019 | $2.99 | $3.09 | +22.0% | |
| 2018 | $2.45 | $2.56 | +800.0% | |
| 2017 | $-0.35 | $-0.35 | -106.8% | |
| 2016 | $5.13 | $5.26 | +2.8% | |
| 2015 | $4.99 | $5.09 | +26.6% | |
| 2014 | $3.94 | $4.03 | -7.9% | |
| 2013 | $4.28 | $4.36 | +0.7% | |
| 2012 | $4.25 | $4.37 | +13.3% | |
| 2011 | $3.75 | $3.86 | +24.2% | |
| 2010 | $3.02 | $3.10 | -49.1% | |
| 2009 | $5.93 | $6.07 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-03 | 0001035267-26-000010 | SEC ↗ |
| 2024-12-31 | 2025-01-31 | 0001035267-25-000017 | SEC ↗ |
| 2023-12-31 | 2024-01-31 | 0001035267-24-000021 | SEC ↗ |
| 2022-12-31 | 2023-02-10 | 0001035267-23-000019 | SEC ↗ |
| 2021-12-31 | 2022-02-03 | 0001035267-22-000014 | SEC ↗ |
| 2020-12-31 | 2021-02-10 | 0001035267-21-000028 | SEC ↗ |
| 2019-12-31 | 2020-02-07 | 0001035267-20-000032 | SEC ↗ |
| 2018-12-31 | 2019-02-04 | 0001035267-19-000012 | SEC ↗ |